Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Telfa Max dressing 38cm x 45.7cm
20030100362
|
Telfa Max dressing 38cm x 45.7cm | Wound Management & Other Dressings | Dressings | No data available |
|
Telfa Max dressing 38cm x 60.9cm
20030100363
|
Telfa Max dressing 38cm x 60.9cm | Wound Management & Other Dressings | Dressings | No data available |
|
Telithromycin 400mg tablets
0501050T0AAAAAA
|
Telithromycin | Telithromycin | Infections | No data available |
|
Telmisartan 40mg/5ml oral suspension
0205052Q0AAADAD
|
Telmisartan | Telmisartan | Cardiovascular System | No data available |
|
Telotristat ethyl 250mg tablets
0104040A0AAAAAA
|
Telotristat ethyl | Telotristat ethyl | Gastro-Intestinal System | No data available |
|
Telzir 50mg/ml oral suspension
0503010M0BBABAB
|
Telzir | Fosamprenavir calcium | Infections | No data available |
|
Telzir 700mg tablets
0503010M0BBAAAA
|
Telzir | Fosamprenavir calcium | Infections | No data available |
|
Temazepam 10mg/5ml oral solution unit dose vials sugar free
0401010T0AABABA
|
Temazepam | Temazepam | Central Nervous System | No data available |
|
Temazepam 14mg/5ml oral liquid
0401010T0AABCBC
|
Temazepam | Temazepam | Central Nervous System | No data available |
|
Temgesic 300micrograms/1ml solution for injection ampoules
0407020B0BBABAA
|
Temgesic | Buprenorphine | Central Nervous System | No data available |
|
Temocillin 1g powder for solution for injection vials
0501012U0AAABAB
|
Temocillin sodium | Temocillin sodium | Infections | No data available |
|
Temodal 100mg capsules
0801050Y0BBAAAA
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 140mg capsules
0801050Y0BBAEAE
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 180mg capsules
0801050Y0BBAFAF
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 20mg capsules
0801050Y0BBADAD
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 250mg capsules
0801050Y0BBABAB
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 5mg capsules
0801050Y0BBACAC
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 100mg capsules
0801050Y0BCACAA
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 140mg capsules
0801050Y0BCADAE
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 180mg capsules
0801050Y0BCAEAF
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 20mg capsules
0801050Y0BCABAD
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 250mg capsules
0801050Y0BCAFAB
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 5mg capsules
0801050Y0BCAAAC
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temoporfin 1mg/1ml solution for injection vials
0801050AKAAABAB
|
Temoporfin | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Temoporfin 20mg/5ml solution for injection vials
0801050AKAAAAAA
|
Temoporfin | Temoporfin | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.